UroGen Pharma Ownership | Who Owns UroGen Pharma?

Overview Forecast RevenueFinancials Chart Transcripts

UroGen Pharma Ownership Summary

UroGen Pharma is owned by 81.50% institutional investors, 9.18% insiders, and 9.32% retail investors. Rtw investments, lp is the largest institutional shareholder, holding 10.66% of URGN shares. UBS (Lux) Digital Health Equity SB USD is the top mutual fund, with 3.13% of its assets in UroGen Pharma shares.

URGN Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	UroGen Pharma	81.50%	9.18%	9.32%
Sector	Healthcare Stocks	49.73%	8.84%	41.43%
Industry	Biotech Stocks	47.04%	8.74%	44.21%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Rtw investments, lp	3.56M	10.66%	$59.69M
Adage capital partners gp	3.30M	9.89%	$55.37M
Great point partners	2.91M	8.71%	$48.77M
Point72 asset management	2.45M	7.34%	$41.10M
Menora mivtachim	2.30M	6.90%	$38.64M
Blackrock	2.19M	6.57%	$36.81M
Cowen and company	2.10M	6.29%	$35.23M
Morgan stanley	1.84M	5.51%	$30.85M
Cormorant asset management, lp	1.65M	4.94%	$27.69M
Ubs asset management americas	1.32M	3.95%	$22.15M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Great point partners	2.91M	9.34%	$48.77M
Silverarc capital management	1.10M	4.36%	$18.49M
Wildcat capital management	495.61K	2.04%	$8.32M
Dafna capital management	469.00K	1.88%	$7.87M
Cormorant asset management, lp	1.65M	1.60%	$27.69M
Opaleye management	412.00K	1.58%	$6.91M
Cowen and company	2.10M	0.97%	$35.23M
Rtw investments, lp	3.56M	0.92%	$59.69M
Parkman healthcare partners	274.46K	0.62%	$4.61M
De lisle partners llp	81.51K	0.30%	$1.37M

Top Buyers

Holder	Shares	% Assets	Change
Adage capital partners gp	3.30M	0.10%	2.00M
Cormorant asset management, lp	1.65M	1.60%	1.65M
Morgan stanley	1.84M	0.00%	1.45M
Point72 asset management	2.45M	0.11%	1.34M
Ubs asset management americas	1.32M	0.01%	1.32M

Top Sellers

Holder	Shares	% Assets	Change
Ra capital management	-	-	-3.08M
Superstring capital management lp	-	-	-288.27K
Price t rowe associates inc /md/	10.95K	-	-256.19K
Harel insurance investments & financial services	463.56K	0.15%	-209.92K
Laurion capital management lp	-	-	-160.60K

New Positions

Holder	Shares	% Assets	Change	Value
Cormorant asset management, lp	1.65M	1.60%	1.65M	$27.69M
Ubs asset management americas	1.32M	0.01%	1.32M	$22.15M
Dafna capital management	469.00K	1.88%	469.00K	$7.87M
Woodline partners lp	303.74K	0.05%	303.74K	$5.10M
Trexquant investment lp	80.71K	0.02%	80.71K	$1.35M

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-4.00
Toronto dominion bank	-6.00
Systm wealth solutions	-48.00
Eversource wealth advisors	-57.00
Lindbrook capital	-87.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	132	9.09%	35,128,434	-8.10%	81	0.76%	75	-5.06%	30	50.00%
Jun 30, 2024	120	2.56%	38,225,515	40.73%	114	2.03%	78	56.00%	20	-45.95%
Mar 31, 2024	117	8.33%	27,162,135	26.89%	75	1.71%	50	-24.24%	37	85.00%
Dec 31, 2023	108	1.89%	21,406,800	20.71%	66	1.16%	66	6.45%	20	-9.09%
Sep 30, 2023	106	19.10%	17,734,025	34.25%	75	2.35%	62	34.78%	22	10.00%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
UBS (Lux) Digital Health Equity SB USD	1.32M	3.13%	-
iShares Russell 2000 ETF	957.94K	2.27%	-2.16K
Fidelity Small Cap Index	351.12K	0.83%	-9.33K
MEDICAL BioHealth EUR Acc	294.71K	0.70%	-238.32K
iShares Biotechnology ETF	269.09K	0.64%	-1.61K
State St Russell Sm/Mid Cp® Indx NL Cl C	262.40K	0.62%	-
iShares Russell 2000 Growth ETF	258.82K	0.61%	-
Vanguard Russell 2000 ETF	172.12K	0.41%	-1.09K
ARK Israel Innovative Technology ETF	161.86K	0.38%	-
SPDR® Portfolio Developed Wld ex-US ETF	120.41K	0.29%	-

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 09, 2024	Schoenberg Mark	Chief Medical Officer	Sell	$11.24K
Sep 09, 2024	Smith Jason Drew	General Counsel	Sell	$19.89K
Jun 10, 2024	Schoenberg Mark	Chief Medical Officer	Sell	$67.40K
Mar 18, 2024	Schoenberg Mark	Chief Medical Officer	Sell	$168.60K
Feb 01, 2024	Smith Jason Drew	General Counsel	Sell	$52.52K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	-	2
2024 Q2	-	1
2024 Q1	-	13
2023 Q3	-	1

URGN Ownership FAQ

Who Owns UroGen Pharma?

UroGen Pharma shareholders are primarily institutional investors at 81.50%, followed by 9.18% insiders and 9.32% retail investors. The average institutional ownership in UroGen Pharma's industry, Biotech Stocks , is 47.04%, which UroGen Pharma exceeds.

Who owns the most shares of UroGen Pharma?

UroGen Pharma’s largest shareholders are Rtw investments, lp (3.56M shares, 10.66%), Adage capital partners gp (3.3M shares, 9.89%), and Great point partners (2.91M shares, 8.71%). Together, they hold 29.25% of UroGen Pharma’s total shares outstanding.

Does Blackrock own UroGen Pharma?

Yes, BlackRock owns 6.57% of UroGen Pharma, totaling 2.19M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 36.81M$. In the last quarter, BlackRock increased its holdings by 477.14K shares, a 27.79% change.

Who is UroGen Pharma’s biggest shareholder by percentage of total assets invested?

Great point partners is UroGen Pharma’s biggest shareholder by percentage of total assets invested, with 9.34% of its assets in 2.91M UroGen Pharma shares, valued at 48.77M$.

Who is the top mutual fund holder of UroGen Pharma shares?

UBS (Lux) Digital Health Equity SB USD is the top mutual fund holder of UroGen Pharma shares, with 3.13% of its total shares outstanding invested in 1.32M UroGen Pharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools